In recent years, automation and artificial intelligence (AI) have been huge trends within the clinical trials landscape, as companies look to incorporate such technologies to optimise their ...

The clinical trial landscape in 2025 was characterised by technological advancements, regulatory innovations, and a focus on diversity and patient engagement, alongside challenges such as declining ...

Multi-trial agreement establishes a standardized digital foundation to support consistent, scalable execution across global studies NEW YORK, Feb. 24, 2026 /PRNewswire/ -- ObvioHealth, a global leader ...

Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) agenda. DHTs are health care focused ...

Boehringer Ingelheim and Microsoft have launched a collaboration to explore the use of AI-powered digital patient twins to improve clinical trial design. | Boehringer Ingelheim and Microsoft have ...

Drug development is an inherently risky endeavour, with the average probability of approval for a drug entering Phase I studies now sitting at just 6.7%. While much of this can be attributed to lack ...

Digital health technologies are transforming respiratory medicine, enhancing home monitoring and enabling decentralized clinical trials in resource-limited settings. The Panacea framework evaluates ...

The pharmaceutical industry is at a critical turning point. Drug discovery has evolved rapidly, but clinical development remains slow, expensive, and inefficient. Clinical trials, especially ...

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Decentralized Clinical Trials Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. Decentralized clinical ...